Research Designs LLC

Research Designs was originally conceived as an incubator for promising technologies in the health sciences field. Currently it is involved in a clinical trial assessing the safety and efficacy of autologous totipotent and pluripotent stem cells in the treatment of neurodegenerative and pulmonary diseases. If you are interested in being considered a candidate for the trial you may contact us at researchdesignsinfo@gmail.com.

Principal Investigator: Mark O. Speight, MD

Research Designs

Non-sponsored clinical trial

A PHASE-IA, NON-BLINDED MULTIPLE CASE STUDY TRIAL INDIVIDUALLY EVALUATING THE SAFETY AND EFFICACY OF USE OF AUTOLOGOUS NUCLEATED PLASMA PARTICLES (NucP2s) FOR THE TREATMENT OF TRAUMATIC BRAIN INJURY, NEURODEGENERATIVE DISEASES AND PULMONARY DISEASES.